Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01835080 · ClinicalTrials.gov registry record
Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)
A clinical trial, sponsored by Inova Health Care Services.
- Terminated
- Registry status
- 2
- Enrollment target
NCT01835080 is a clinical trial that was terminated before completion, run by Inova Health Care Services. The registered enrollment target is 2 participants.
The verdict
NCT01835080 was terminated before completion, sponsored by Inova Health Care Services.
- TERMINATED
- Registry status
- 2 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether pulmonary arterial hypertension can worsen or even cause sleep apnea. It is hypothesized that if pulmonary arterial hypertension does indeed worsen or cause sleep apnea, then the treatment should first focus on the underlying pulmonary arterial hypertension instead of the sleep apnea. To determine if a person has sleep apnea, they will undergo one overnight polysomnogram (sleep study). If it is found that they have mild to moderate sleep apnea, then the subject will be invited to continue in the study and their pulmonary arterial hypertension will be treated by their managing primary physician. After the subject has had treatment for their pulmonary arterial hypertension, the study center will have them return for a follow up sleep study to learn the effects of pulmonary arterial hypertension treatment management on their sleep apnea, 12-24 weeks after the first sleep study.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2013-04 |
| Est. Completion | 2014-03 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01835080
The ClinicalTrials.gov registry entry for NCT01835080 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Inova Health Care Services, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01835080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01835080 about?
NCT01835080 is a clinical study titled "Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)". The purpose of this study is to determine whether pulmonary arterial hypertension can worsen or even cause sleep apnea. It is hypothesized that if pulmonary arterial hypertension does indeed worsen or cause sleep apnea, then the treatment should first focus on the underlying pulmonary arterial hyper...
What is the current status of trial NCT01835080?
This trial is currently terminated. The enrollment target is 2 participants. The study started on 2013-04. Estimated completion is 2014-03.
Who is sponsoring clinical trial NCT01835080?
This trial is sponsored by Inova Health Care Services, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.